Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Rontalizumab [USAN:INN]
RN: 948570-30-7
UNII: LDO2FIQ61I

Note

  • Targets interferon-alpha.

Molecular Formula

  • C6486-H9990-N1722-O2026-S44
 

Classification Code

  • Treatment of Systemic Lupus Erythematosus (SLE)
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Rontalizumab [USAN:INN]

Synonyms

  • Immunoglobulin G1, anti-(human interferons alpha type); humanized mouse monoclonal rhuMAB IFNalpha gamma1 heavy chain (des-CH3(sup 107)K, CH1(sup 97)R>K-IGHG1*03) (220-218')-disulfide with humanized mouse monoclonal rhuMAB IFNalpha kappa light chain, dimer (226-226'':229-229'')-bisdisulfide
  • RhuMAb IFNalpha
  • Rontalizumab
  • UNII-LDO2FIQ61I

Systematic Name

  • Immunoglobulin G1, anti-(human interferon alpha) (human-mouse monoclonal rhuMAb IFNalpha heavy chain), disulfide with human-mouse monoclonal rhuMAb IFNalpha kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 948570-30-7

FDA UNII

  • LDO2FIQ61I

System Generated Number

  • 0948570307